Sanara MedTech Inc (SMTI)
31.51
-1.02
(-3.14%)
USD |
NASDAQ |
May 21, 16:00
31.89
+0.38
(+1.21%)
After-Hours: 20:00
Sanara MedTech 1 Year Total Returns (Daily): -15.48% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -15.48% |
May 20, 2024 | -12.74% |
May 17, 2024 | -19.84% |
May 16, 2024 | -18.68% |
May 15, 2024 | -19.99% |
May 14, 2024 | -27.26% |
May 13, 2024 | -28.67% |
May 10, 2024 | -17.53% |
May 09, 2024 | -12.33% |
May 08, 2024 | -14.09% |
May 07, 2024 | -11.38% |
May 06, 2024 | -13.86% |
May 03, 2024 | -17.35% |
May 02, 2024 | -20.47% |
May 01, 2024 | -21.49% |
April 30, 2024 | -24.10% |
April 29, 2024 | -22.69% |
April 26, 2024 | -23.70% |
April 25, 2024 | -24.73% |
April 24, 2024 | -26.72% |
April 23, 2024 | -29.12% |
April 22, 2024 | -28.46% |
April 19, 2024 | -28.38% |
April 18, 2024 | -29.01% |
April 17, 2024 | -35.06% |
Date | Value |
---|---|
April 16, 2024 | -34.58% |
April 15, 2024 | -33.34% |
April 12, 2024 | -29.24% |
April 11, 2024 | -33.64% |
April 10, 2024 | -33.55% |
April 09, 2024 | -26.97% |
April 08, 2024 | -25.68% |
April 05, 2024 | -22.05% |
April 04, 2024 | -21.80% |
April 03, 2024 | -16.93% |
April 02, 2024 | -14.64% |
April 01, 2024 | -11.64% |
March 28, 2024 | -2.91% |
March 27, 2024 | -3.79% |
March 26, 2024 | -4.25% |
March 25, 2024 | -5.55% |
March 22, 2024 | -6.24% |
March 21, 2024 | -5.61% |
March 20, 2024 | -5.18% |
March 19, 2024 | -6.92% |
March 18, 2024 | -9.00% |
March 15, 2024 | -7.68% |
March 14, 2024 | -13.04% |
March 13, 2024 | -9.02% |
March 12, 2024 | -9.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-50.71%
Minimum
Dec 21 2021
475.0%
Maximum
Dec 11 2019
72.15%
Average
41.79%
Median
Mar 29 2023
1 Year Total Returns (Daily) Benchmarks
AptarGroup Inc | 26.38% |
Daxor Corp | -20.92% |
Precision Optics Corp Inc | 9.30% |
Warby Parker Inc | 49.82% |
Perspective Therapeutics Inc | 227.0% |